Patent Assignment
Reel/Frame 029806/0659
Assignment of Assignor's Interest
Recorded: 2013-02-13
Pages: 3
Assignor
HOLERS, V. MICHAEL
Executed: 2011-01-27
Assignee
TALIGEN THERAPEUTICS, INC.
245 FIRST STREET, SUITE 1100, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Treatment of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias and Disease States Involving Intravascular and Extravascular Hemolysis
Patent:
10,239,937 →
Application:
13/505,150 →
Publication:
US 2013/0029912
PCT:
PCT/US2010/055745 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Feb 13, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029806/0744 →
Assignment of Assignor's Interest
Feb 13, 2013
From: HOLERS, V. MICHAEL
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029806/0793 →
Merger
Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →